Assembly Biosciences, Inc. Trading Securities, Change in Unrealized Holding Gain (Loss)
Assembly Biosciences, Inc. (ASMB) reported Trading Securities, Change in Unrealized Holding Gain (Loss) of $52.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Income Statement › Other Income
us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss · last filed 2019-08-05
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for the quarter ending 2019-06-30 was $52.00K, a 40.23% decline year-over-year.
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for the quarter ending 2019-03-31 was $108.00K.
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for the quarter ending 2018-12-31 was $7.50K.
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for the quarter ending 2018-09-30 was $17.50K, a 77.11% increase year-over-year.
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for fiscal 2018 was $45.00K, a 78.47% decline from fiscal 2017.
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for fiscal 2017 was $209.00K, a 5.43% decline from fiscal 2016.
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for fiscal 2016 was $221.00K.
- Assembly Biosciences, Inc. trading securities, change in unrealized holding gain (loss) for fiscal 2015 was -$821.59K.
| Period end | Trading Securities, Change in Unrealized Holding Gain (Loss) 3 month | Trading Securities, Change in Unrealized Holding Gain (Loss) 3 month as first filed | Trading Securities, Change in Unrealized Holding Gain (Loss) 6 month | Trading Securities, Change in Unrealized Holding Gain (Loss) 6 month as first filed | Trading Securities, Change in Unrealized Holding Gain (Loss) 9 month | Trading Securities, Change in Unrealized Holding Gain (Loss) 12 month | Trading Securities, Change in Unrealized Holding Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2019-06-30 | $52.00K 10-Q · filed 2019-08-05 | $160.00K 10-Q · filed 2019-08-05 | $167.50K derived: sum of 3 quarters · filed 2019-08-05 | $185.00K derived: sum of 4 quarters · filed 2019-08-05 | |||
| 2019-03-31 | $108.00K 10-Q · filed 2019-05-09 | $115.50K derived: sum of 2 quarters · filed 2019-05-09 | $133.00K derived: sum of 3 quarters · filed 2019-05-09 | $220.00K derived: sum of 4 quarters · filed 2019-08-05 | |||
| 2018-12-31 | $7.50K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $25.00K derived: sum of 2 quarters · filed 2019-02-28 | $112.00K derived: sum of 3 quarters · filed 2019-08-05 | $45.00K 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $17.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $104.50K derived: sum of 2 quarters · filed 2019-08-05 | $37.49K 10-Q · filed 2018-11-08 | $34.12K derived: sum of 4 quarters · filed 2019-08-05 | |||
| 2018-06-30 | $87.00K 10-Q · filed 2019-08-05 | $20.00K 10-Q · filed 2019-08-05 | $20.31K 10-Q · filed 2018-08-08 | $16.62K derived: sum of 3 quarters · filed 2019-08-05 | $26.50K derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2018-03-31 | -$67.00K 10-Q · filed 2019-05-09 | -$66.96K 10-Q · filed 2018-05-07 | -$70.38K derived: sum of 2 quarters · filed 2019-05-09 | -$60.50K derived: sum of 3 quarters · filed 2019-05-09 | $65.91K derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$3.38K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $6.50K derived: sum of 2 quarters · filed 2019-02-28 | $132.91K derived: sum of 3 quarters · filed 2019-02-28 | $209.00K 10-K · filed 2019-02-28 | $208.38K 10-K · filed 2018-03-08 | ||
| 2017-09-30 | $9.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $136.29K derived: sum of 2 quarters · filed 2017-11-01 | $212.38K 10-Q · filed 2017-11-01 | $448.36K derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $126.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $202.50K 10-Q · filed 2017-08-09 | $438.49K derived: sum of 3 quarters · filed 2019-02-28 | $441.28K derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $76.09K 10-Q · filed 2017-05-08 | $312.07K derived: sum of 2 quarters · filed 2019-02-28 | $314.87K derived: sum of 3 quarters · filed 2019-02-28 | $225.00K derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $235.98K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $238.78K derived: sum of 2 quarters · filed 2019-02-28 | $148.91K derived: sum of 3 quarters · filed 2019-02-28 | $221.00K 10-K · filed 2019-02-28 | $220.82K 10-K · filed 2017-03-02 | ||
| 2016-09-30 | $2.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$87.07K derived: sum of 2 quarters · filed 2016-11-09 | -$14.98K 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | -$89.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$17.78K 10-Q · filed 2016-08-09 | |||||
| 2016-03-31 | $72.09K 10-Q · filed 2016-05-10 | ||||||
| 2015-12-31 | -$821.59K 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |